Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Changes in pulmonary function, 6-minute walk test, and health-related quality of life before and after 12 weeks of pulmonary rehabilitation

From: Exercise training with negative pressure ventilation improves exercise capacity in patients with severe restrictive lung disease: a prospective controlled study

  Non-NPV-exercise group NPV-exercise group
Baseline 12 weeks Baseline 12 weeks
(n = 18) (n = 18) (n = 18) (n = 18)
FVC, % predicted 37.7 ± 2.4 37.9 ± 3.2 32.6 ± 2.8 35.1 ± 2.7a
FEV1, % predicted 42.2 ± 2.9 43.9 ± 4.3 36.9 ± 3.2 40.3 ± 3.3a
FEV1/FVC, % 84.1 ± 8.6 83.6 ± 7.8 82.9 ± 9.4 83.5 ± 10.8
6MWD, m 362.8 ± 99.4 330.3 ± 94.4 371.3 ± 77.9 405.4 ± 78.1a
SaO2, % pre/post 6MWT 94.0/ 81.4 93.2/ 76.8 93.9/ 77.0 94.6/ 79.1
HR, pre/ post 6MWT 98.2/ 125.8 101.4/ 127.7 103.3/ 126.7 92.0/ 123.4
Borg, pre/ post 6MWT 0.5/ 5.0 1.5/ 7.0 1.25/ 5.0 0/ 4.5a
 (range) (0–4)/ (3–10) (0–4)/ (2–9) (0–4)/ (4–8) (0–4)/ (1–8)
Limb muscle power     
 R-upper limb, lb 32.9 ± 1.8b 32.3 ± 1.6b 31.0 ± 2.1c 33.5 ± 2.2a, c
 L-upper limb, lb 30.2 ± 3.5b 33.0 ± 4.7b 29.6 ± 1.6c 30.3 ± 1.6c
 R-low limb, lb 44.3 ± 3.9b 46.2 ± 4.9b 38.5 ± 3.0c 41.4 ± 2.3c
 L-low limb. lb 41.2 ± 3.4b 41.3 ± 4.6b 38.2 ± 2.7c 40.7 ± 2.2c
SGRQ     
 Symptom score 48.2 ± 6.0e 46.5 ± 6.1e 54.6 ± 5.0 24.5 ± 4.0a
 Active score 61.6 ± 6.0e 72.3 ± 6.1e 53.7 ± 5.8 45.9 ± 5.6a
 Impacts score 30.0 ± 4.2e 46.7 ± 7.0a,e 36.2 ± 5.7 22.6 ± 5.1a
 Total score 42.6 ± 4.6e 54.4 ± 4.9e 44.6 ± 4.8 30.0 ± 4.4a
  1. Values are mean ± SD.
  2. a p < 0.05, baseline vs. 12 weeks.
  3. b only 6 patients in the non-NPV exercise group received limb muscle tests.
  4. c 17 patients in the NPV exercise group received limb muscle tests.
  5. e only 10 patients in the non-NPV exercise group completed the SGRQ at 12 weeks.